PMID: 9163617May 1, 1997Paper

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

British Journal of Haematology
I KhouriR Champlin

Abstract

The outcome of allogeneic haemopoietic transplants including the rate of immune complications for patients with chronic lymphocytic leukaemia (CLL) refractory to or relapsing after chemotherapy with fludarabine was analysed. Fifteen patients with advanced CLL who received allogeneic transplantation were prospectively analysed. All patients had previously received chemotherapy with fludarabine for 3-15 courses; 12 were refractory. The median number of circulating CD4+ and CD8+ lymphocytes at the time of transplant was 0.49 x 10(9)/l and 0.23 x 10(9)/l, respectively. One patient was transplanted from a one HLA-antigen mismatched unrelated donor. Three others received a one or two antigen mismatched graft and 11 had HLA-identical sibling donors. Patients received cyclosporine or tacrolimus in addition to methotrexate or methylprednisolone for prophylaxis of acute graft-versus-host disease (aGVHD). Fourteen patients engrafted; one patient had graft failure, but recovered after therapy with intravenous immunoglobulin. 13 (87%) achieved complete remission (CR). Nine (53%) remain alive and in CR with a median follow-up of 36 (range 3-60) months. None developed visceral graft-versus-host disease. These data compared favourably to publi...Continue Reading

Associated Clinical Trials

Citations

Aug 31, 2002·Hematological Oncology·Gerassimos A PangalisMaria K Angelopoulou
Apr 15, 2003·European Journal of Nuclear Medicine and Molecular Imaging·J CoffeyM K Gospodarowicz
Sep 21, 2004·Springer Seminars in Immunopathology·Marco BregniJacopo Peccatori
Sep 16, 2004·Springer Seminars in Immunopathology·Tatyana Prigozhina, Shimon Slavin
Jan 5, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M J Keating
Sep 21, 2000·Critical Reviews in Oncology/hematology·N SabaA Keating
Aug 5, 2000·Transfusion·T Repka, D J Weisdorf
Jan 11, 2005·British Journal of Haematology·S Paneesha, D W Milligan
Mar 25, 2000·Drugs & Aging·N Kalil, B D Cheson
Jan 1, 2010·Mediterranean Journal of Hematology and Infectious Diseases·Luca LaurentiSimona Sica
Feb 1, 2007·Current Hematologic Malignancy Reports·Rifca Le Dieu, John G Gribben
Feb 13, 2001·European Journal of Haematology·L Vindeløv
Jul 14, 2010·Best Practice & Research. Clinical Haematology·Simon Hallam, John G Gribben
Sep 26, 2009·Clinical Lymphoma & Myeloma·Simon Hallam, John G Gribben
Aug 21, 2007·Best Practice & Research. Clinical Haematology·John G Gribben
Jul 23, 2004·Seminars in Hematology·V Rizouli, J g Gribben Jg
Jun 1, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ronald M SobecksWael Saber
Dec 2, 2004·Expert Opinion on Pharmacotherapy·Meghan HigmanAllen Chen
Jan 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John G GribbenDavid G Maloney
Jan 29, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John G Gribben
Jul 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven Z PavleticClaudio Anasetti
Apr 8, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Uri RozovskiZeev Estrov
Oct 14, 2005·Expert Review of Anticancer Therapy·Edgardo S SantosHana Safah
Nov 30, 1999·Hematology/oncology Clinics of North America·M E FlowersK M Sullivan
Apr 4, 2000·Bone Marrow Transplantation·Z S PavleticM R Bishop
Mar 21, 2000·Bone Marrow Transplantation·A M CarellaR Storb
Jul 4, 2001·Bone Marrow Transplantation·R ChamplinS Giralt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.